PATENT CLAIM ANALYSIS

Application Number: 16031418
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "141100"]

Abstract:
The present invention is directed to an anti-prion monoclonal antibody and its use for the treatment of conditions associated with or mediated by proteins or peptides having a toxic oligomeric form. These conditions include, but are not limited to, Alzheimer's disease, frontotemporal dementias, traumatic brain injury, and chronic traumatic encephalopathy.

Claim (Index 15):
The antibody or binding fragment thereof of  claim 1 , wherein said antibody or binding fragment thereof comprises:\n a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 4 and a light chain variable region comprising the amino acid sequence of SEQ ID NO: 8.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 95.0
- Lexical Diversity: 1.20833
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13773264', '12999045', '14616300', '15324141', '14407724']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7041317990545115
- 35 USC 102 Novelty (BERT): 0.53810548447469
- Combined Prediction Score: 0.6875291675965294
- Mean Citation Score: 357.33605400000016
- Max Citation Score: 366.13882
- Similarity Product: 272.22351222055914

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test